Predicting memory decline with brain and blood tests
Part of Brain & nervous system, Mental health clinical trials.
This study follows older adults with normal memory, mild memory problems, or dementia over a year to see if brain scans and blood tests can predict who will get worse. It may help find early warning signs of Alzheimer's and other dementias.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years old or older
- You can attend study visits and follow-up appointments for 1 year
- You have either normal memory, mild memory problems, or dementia
- If you have memory problems or dementia, a Chinese-speaking caregiver who lives with you or sees you at least 4 days a week can join you
- You have no recent stroke, severe mental illness, terminal illness, or severe vision/hearing problems that would make testing hard
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood and imaging markers (biomarkers) to better understand and diagnose dementia and mild cognitive impairment. It aims to improve early detection and may help guide future treatments.
This study checks how age affects memory and thinking, and compares people with mild memory problems, Alzheimer’s disease types, vascular dementia, and healthy controls. You may help researchers understand brain changes using thinking tests, MRI scans, and blood or spinal fluid tests.
This study follows people with normal thinking, early memory problems, or Alzheimer's disease to understand how the brain changes over time. Researchers will use smell tests, blood work, and memory testing to learn more about these conditions and potentially help future treatments.
This study looks for “biomarkers” (measurable signs from blood and brain tests) that may help predict who with mild cognitive impairment (MCI) could later develop dementia. Results may help doctors spot risk earlier and better plan care.
This trial looks for new ways to diagnose memory and thinking problems earlier. It involves a memory test, brain scan, and blood draw to find markers that could help identify cognitive disorders.
This study is testing whether simple blood tests can help doctors better understand the type and progression of memory or thinking problems in people with early dementia. It aims to improve confidence in the diagnosis and future outlook.
Hear when a new Mild Cognitive Impairment (MCI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.